P45 An analysis of infantile haemangioma referrals and comparison with the infantile haemangioma European task force’s ‘infantile haemangioma referral score’

Abstract Infantile haemangiomas (IHs) are common. Timely referral and treatment can minimize complications in high-risk lesions. The IH European Task Force developed the Haemangioma Referral Score (IHRes) 2020 (Léauté-Labrèze C, Torres EB, Weibel L et al. Hemangioma Score: a validated tool for physicians. Pediatrics 2020; 145:e20191628). This is simple, easy-to-access screening that assist physicians deciding which IHs to refer an expert centre. aim of this study was assess quality referrals national care Data were retrospectively collected from random sample patients over 13-month period between January 2019 February 2020. Fifty-six included. Eighty-six per cent had solitary haemangioma (n = 48); 52% located on head 29). Sixteen (29%) referred 5 8 weeks age (29%); five (9%) before age. majority came primary (55%; n 31). Seventy-three referrers did not specify urgency 41); 59% subsequently triaged as urgent by consultant dermatologist 33). Most size (43%; 24), if it actively growing (48%; 27), ulcerated (93%; 52) or potentially function threatening (84%; 47). Nine included photograph lesion 5). Seventy-five satisfied IHRes six major criteria scores > 4, warranting 42). Fifteen (27%) started propranolol at first appointment further 12 monitored return appointment. Our results show use IHReS could improve clinical outcomes identifying children require specialist earlier facilitate easier triage referrals.